Restless Legs Clinical Trial, Recruiting Patients for Study: "The primary objective of the current study will be the evaluation of long-term efficacy of a 26-weeks treatment with pramipexole in patients with idiopathic moderate to severe Restless Legs Syndrome in comparison to placebo. "
Sunday, May 27, 2007
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment